Immune Monitor-- COG Trial of Anti-GD2 in Neuroblastoma

Yu, Alice L.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Food and Drug Administration (FDA)
• Type: Research Project (R01)
• Project #: 5R01FD002319-03
• Application #: 7128922
• Study Section: Special Emphasis Panel (ZFD1-SRC (99))
• Program Officer: Springer, Rosemary T
• Project Start: 2003-09-30
• Project End: 2010-05-31
• Budget Start: 2005-09-30
• Budget End: 2008-05-31
• Support Year: 3
• Fiscal Year: 2005

Institution

• Name: University of California San Diego
• Department: Pediatrics
• Type: Schools of Medicine
• DUNS #: 804355790
• City: La Jolla
• State: CA
• Country: United States
• Zip Code: 92093

Publications

Yu, Alice L; Gilman, Andrew L; Ozkaynak, M Fevzi et al. (2010) Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 363:1324-34

Gilman, Andrew L; Ozkaynak, M Fevzi; Matthay, Katherine K et al. (2009) Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group. J Clin Oncol 27:85-91